IL131489A0 - Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylphyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid - Google Patents
Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylphyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acidInfo
- Publication number
- IL131489A0 IL131489A0 IL13148998A IL13148998A IL131489A0 IL 131489 A0 IL131489 A0 IL 131489A0 IL 13148998 A IL13148998 A IL 13148998A IL 13148998 A IL13148998 A IL 13148998A IL 131489 A0 IL131489 A0 IL 131489A0
- Authority
- IL
- Israel
- Prior art keywords
- phenylphyrrolidin
- indole
- dichloro
- oxo
- carboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
| PCT/EP1998/001146 WO1998039327A1 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL131489A0 true IL131489A0 (en) | 2001-01-28 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13148998A IL131489A0 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylphyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (xx) |
| JP (1) | JP2001513796A (xx) |
| KR (1) | KR20000075907A (xx) |
| CN (1) | CN1249750A (xx) |
| AP (1) | AP9901637A0 (xx) |
| AR (1) | AR011178A1 (xx) |
| AU (1) | AU6825198A (xx) |
| BG (1) | BG103779A (xx) |
| BR (1) | BR9808305A (xx) |
| CA (1) | CA2282851A1 (xx) |
| CO (1) | CO4940415A1 (xx) |
| EA (1) | EA199900710A1 (xx) |
| EE (1) | EE9900387A (xx) |
| GB (1) | GB9704498D0 (xx) |
| HR (1) | HRP980114A2 (xx) |
| HU (1) | HUP0002109A2 (xx) |
| ID (1) | ID24207A (xx) |
| IL (1) | IL131489A0 (xx) |
| IS (1) | IS5166A (xx) |
| NO (1) | NO994303L (xx) |
| NZ (1) | NZ337315A (xx) |
| OA (1) | OA11154A (xx) |
| PE (1) | PE51399A1 (xx) |
| PL (1) | PL335652A1 (xx) |
| SK (1) | SK119699A3 (xx) |
| TR (1) | TR199902117T2 (xx) |
| WO (1) | WO1998039327A1 (xx) |
| YU (1) | YU43499A (xx) |
| ZA (1) | ZA981791B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| RU2020100230A (ru) | 2017-06-12 | 2021-07-13 | Глитек Ллс. | Лечение депрессии антагонистами nmda и антагонистами d2/5-ht2a или селективными антагонистами 5-нт2a |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 PE PE1998000149A patent/PE51399A1/es not_active Application Discontinuation
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/ko not_active Application Discontinuation
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/xx unknown
- 1998-03-03 CN CN98803053A patent/CN1249750A/zh active Pending
- 1998-03-03 AR ARP980100948A patent/AR011178A1/es unknown
- 1998-03-03 CO CO98011404A patent/CO4940415A1/es unknown
- 1998-03-03 EA EA199900710A patent/EA199900710A1/ru unknown
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/pt not_active Application Discontinuation
- 1998-03-03 SK SK1196-99A patent/SK119699A3/sk unknown
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Application Discontinuation
- 1998-03-03 ID IDW990976A patent/ID24207A/id unknown
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 JP JP53813598A patent/JP2001513796A/ja active Pending
- 1998-03-03 IL IL13148998A patent/IL131489A0/xx unknown
- 1998-03-03 PL PL98335652A patent/PL335652A1/xx unknown
- 1998-03-03 YU YU43499A patent/YU43499A/sh unknown
- 1998-03-03 EE EEP199900387A patent/EE9900387A/xx unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/xx unknown
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/hu unknown
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/hr not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/is unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/fr unknown
- 1999-09-03 NO NO994303A patent/NO994303L/no not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1249750A (zh) | 2000-04-05 |
| BG103779A (en) | 2000-06-30 |
| WO1998039327A1 (en) | 1998-09-11 |
| HRP980114A2 (en) | 1998-12-31 |
| YU43499A (sh) | 2000-12-28 |
| ID24207A (id) | 2000-07-13 |
| TR199902117T2 (xx) | 2000-03-21 |
| NZ337315A (en) | 2001-02-23 |
| OA11154A (en) | 2003-04-16 |
| AP9901637A0 (en) | 1999-09-30 |
| AR011178A1 (es) | 2000-08-02 |
| EE9900387A (et) | 2000-04-17 |
| IS5166A (is) | 1999-08-27 |
| SK119699A3 (en) | 2000-05-16 |
| CA2282851A1 (en) | 1998-09-11 |
| CO4940415A1 (es) | 2000-07-24 |
| JP2001513796A (ja) | 2001-09-04 |
| NO994303L (no) | 1999-11-03 |
| PL335652A1 (en) | 2000-05-08 |
| NO994303D0 (no) | 1999-09-03 |
| EP0966463A1 (en) | 1999-12-29 |
| EA199900710A1 (ru) | 2000-04-24 |
| AU6825198A (en) | 1998-09-22 |
| KR20000075907A (ko) | 2000-12-26 |
| BR9808305A (pt) | 2000-05-16 |
| GB9704498D0 (en) | 1997-04-23 |
| HUP0002109A2 (hu) | 2001-04-28 |
| PE51399A1 (es) | 1999-06-07 |
| ZA981791B (en) | 1999-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1026699A1 (en) | Crystalline form of omeprazole sodium salt | |
| AU2175799A (en) | Flash memory system | |
| IL139470A0 (en) | Oxyiminoalkanoic acid derivatives | |
| EG23980A (en) | Potassium salt of (s)-omeprazole | |
| AU1978699A (en) | Heterocyclic compounds | |
| IL149420A0 (en) | Heterocyclic substituted pyrazolones | |
| CZ56397A3 (cs) | Soli derivátů indolu | |
| PL339659A1 (en) | Crystalline antimycotic polymorph | |
| HK1035525A1 (en) | Aminomethylcarboxylic acid derivatives | |
| HK1044481A1 (zh) | 化合物 | |
| AU1917899A (en) | Crystalline sodium phenytoin monohydrate | |
| IL145962A0 (en) | Pesticidal indazole or benzotriazole derivatives | |
| HUP9801924A3 (en) | Combination containing sodium/hydrogen exchange inhibitors | |
| GB9825988D0 (en) | Indole derivatives | |
| IL131489A0 (en) | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylphyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid | |
| AU5767098A (en) | Stabilized sodium carbonate peroxyhydrate | |
| AU8179198A (en) | Nucleobase heterocyclic combinatorialization | |
| IL144494A0 (en) | Cartridge for dialysis containing sodium bicarbonate | |
| HK1044482A1 (zh) | 化合物 | |
| MA26840A1 (fr) | Cristaux d'inhibiteur d'echangeur sodium-hydrogene de type 1 | |
| DE50013257D1 (de) | Hochalkalisches kristallines Natriumsilikat | |
| AU1719700A (en) | Selective inhibitors of mmp-12 | |
| SI0991641T1 (en) | Crystalline form of omeprazole sodium salt | |
| EP1242075A4 (en) | indole compounds | |
| HU9904011D0 (en) | Novel salts of dipeptid derivatives |